The first stop for professional medicines advice

Respiratory disorders

16 results

Applied filters

The licence and supporting evidence for omalizumab biosimilar

19 September 2025We highlight evidence for licensed omalizumab biosimilar(s) and differences between the biosimilar(s) and the reference product (Xolair).

Preparing to use omalizumab biosimilar

19 September 2025Omalizumab biosimilars are expected soon. We offer general information and implementation advice.

Clarithromycin for sinusitis

1 February 2024SPS PGD template for the supply of clarithromycin for sinusitis in penicillin allergy and where an intranasal steroid is unsuitable or ineffective.

Clarithromycin for otitis media

1 February 2024SPS PGD template for the supply of clarithromycin for otitis media in those with a penicillin allergy.

Fluticasone furoate nasal spray for sinusitis

1 February 2024SPS PGD template for the supply of fluticasone furoate nasal spray for sinusitis.

Otigo (phenazone with lidocaine) ear drops for otitis media

1 February 2024SPS PGD template for the supply of Otigo (phenazone with lidocaine) ear drops for symptomatic relief of pain due to otitis media.

Penicillin V (phenoxymethylpenicillin) for sinusitis

1 February 2024SPS PGD template for the supply of penicillin V (phenoxymethylpenicillin) where an intranasal steroid is unsuitable or ineffective.

Amoxicillin for otitis media

1 February 2024SPS PGD template for the supply of amoxicillin for otitis media.

Erythromycin for sore throat

1 February 2024SPS PGD template for the supply of erythromycin for sore throat in both penicillin allergy and pregnancy.

Erythromycin for otitis media

1 February 2024SPS PGD template for the supply of erythromycin for otitis media in both penicillin allergy and pregnancy.